Cipla LtdNSE: CIPLA

Cipla Ltd Press Release Dec 10 2023

· Issued by Cipla Ltd via NSE India

Filed with NSE · · 3 pages · English

Summary by 6ix AI

The recall affects a lot that may lead to underdosing, posing risks primarily to infants and young children. Cipla has not received reports of adverse events related to this recall and is coordinating the return of the affected products.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Cipla Limited has informed the Exchange regarding a press release dated December 10, 2023, titled "Voluntary Nationwide Recall of one lot of Vigabatrin for Oral Solution, USP 500mg due to leaking sachets by InvaGen Pharmaceuticals Inc., wholly owned subsidiary of the Company in USA".

Cipla Ltd on 6ix

Earlier from Cipla

Later from Cipla

All Cipla news releases